The present invention provides a novel synergistic pharmaceutical co-crystal of Mesalamine or its pharmaceutically acceptable salts as API along with coformers such as alpha amino acids, flavones or nutraceuticals for the treatment of inflammatory bowel disease, Crohn"s disease, ulcerative colitis, indeterminate col...
The present invention discloses novel synergistic pharmaceutical co-crystals of Metformin or its pharmaceutically acceptable salts and oleoylethanolamide in fixed stoichiometric ratio at lower dosage, with improved residence time thereby increasing the bioavailability and efficacy, as anti- diabetic agent. The inven...
Disclosed herein in the present invention is the co-crystal comprising Quercetin and Isoniazid characterized by characterized by PXRD and IR and Mass spectra useful for treating tuberculosis.
Charges
1 Crore
22 August 2005
Canara Bank
1 Crore
22 August 2005
Canara Bank
0
22 August 2005
Canara Bank
0
Documents
Form DIR-11-13122018_signed
Notice of resignation filed with the company-13122018
Proof of dispatch-13122018
Notice of resignation filed with the company-05122018
Form DIR-11-05122018_signed
Proof of dispatch-05122018
Form AOC-4-19012018_signed
Form MGT-7-19012018_signed
Form AOC-4-18012018_signed
Form MGT-7-18012018_signed
Optional Attachment-(3)-17012018
Optional Attachment-(2)-17012018
List of share holders, debenture holders;-17012018
Directors report as per section 134(3)-17012018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-17012018
Optional Attachment-(1)-17012018
List of share holders, debenture holders;-20042016
Directors report as per section 134(3)-20042016
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-20042016